Abstract
In rheumatoid arthritis, synovial expression of urokinase (uPA) activity is greatly increased (Busso, N., V. Péclat, A. So, and A. -P. Sappino. 1997. Ann. Rheum. Dis. 56:550- 557). We report the same effect in murine antigen-induced arthritis. uPA-mediated plasminogen activation in arthritic joints may have deleterious effects via degradation of cartilage and bone matrix proteins as well as beneficial effects via fibrin degradation. We evaluated these contrasting effects in vivo by analyzing the phenotype of uPA-deficient (uPA-/-) and control mice during antigen-induced arthritis. Joint inflammation was comparable in both groups up to day 3 and subsequently declined in control mice, remaining significantly elevated in uPA-/- mice on days 10 and 30 after arthritis onset. Likewise, synovial thickness was markedly increased in uPA-deficient mice persisting for up to 2 mo, whereas it subsided in control animals. Bone erosion was exacerbated in uPA-/- mice on day 30. By contrast, no difference in articular cartilage proteoglycan content was found between both groups. Significantly increased accumulation of fibrin was observed by day 30 in arthritic joints of uPA-/- mice. We hypothesized that synovial fibrin deposition plays a role in joint inflammation. Accordingly, defibrinogenation of uPA-/- mice by ancrod significantly decreased the sustained joint inflammation. All the above observations were reproducible in plasminogen-deficient (Pln-/-) mice. In conclusion, synovial fibrin deposition plays a role as a nonimmunological mechanism which sustains chronic arthritis.
Full Text
The Full Text of this article is available as a PDF (12.3 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barazzone C., Belin D., Piguet P. F., Vassalli J. D., Sappino A. P. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest. 1996 Dec 15;98(12):2666–2673. doi: 10.1172/JCI119089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belcher C., Fawthrop F., Bunning R., Doherty M. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees. Ann Rheum Dis. 1996 Apr;55(4):230–236. doi: 10.1136/ard.55.4.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bell W. R., Shapiro S. S., Martinez J., Nossel H. L. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man. J Lab Clin Med. 1978 Apr;91(4):592–604. [PubMed] [Google Scholar]
- Bos R., van Leuven C. J., Stolk J., Hiemstra P. S., Ronday H. K., Nieuwenhuizen W. An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis. Eur J Clin Invest. 1997 Feb;27(2):148–156. doi: 10.1046/j.1365-2362.1997.810634.x. [DOI] [PubMed] [Google Scholar]
- Brackertz D., Mitchell G. F., Mackay I. R. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum. 1977 Apr;20(3):841–850. doi: 10.1002/art.1780200314. [DOI] [PubMed] [Google Scholar]
- Brommer E. J., Dooijewaard G., Dijkmans B. A., Breedveld F. C. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Thromb Haemost. 1992 Aug 3;68(2):180–184. [PubMed] [Google Scholar]
- Bugge T. H., Flick M. J., Daugherty C. C., Degen J. L. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 1995 Apr 1;9(7):794–807. doi: 10.1101/gad.9.7.794. [DOI] [PubMed] [Google Scholar]
- Bugge T. H., Kombrinck K. W., Flick M. J., Daugherty C. C., Danton M. J., Degen J. L. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 1996 Nov 15;87(4):709–719. doi: 10.1016/s0092-8674(00)81390-2. [DOI] [PubMed] [Google Scholar]
- Bugge T. H., Kombrinck K. W., Xiao Q., Holmbäck K., Daugherty C. C., Witte D. P., Degen J. L. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood. 1997 Dec 1;90(11):4522–4531. [PubMed] [Google Scholar]
- Busso N., Masur S. K., Lazega D., Waxman S., Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol. 1994 Jul;126(1):259–270. doi: 10.1083/jcb.126.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Busso N., Péclat V., So A., Sappino A. P. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis. 1997 Sep;56(9):550–557. doi: 10.1136/ard.56.9.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Campbell I. K., Piccoli D. S., Roberts M. J., Muirden K. D., Hamilton J. A. Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum. 1990 Apr;33(4):542–552. doi: 10.1002/art.1780330412. [DOI] [PubMed] [Google Scholar]
- Carmassi F., De Negri F., Morale M., Puccetti R., Chung S. I. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis. Int J Tissue React. 1994;16(2):89–93. [PubMed] [Google Scholar]
- Carmeliet P., Moons L., Lijnen R., Baes M., Lemaître V., Tipping P., Drew A., Eeckhout Y., Shapiro S., Lupu F. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997 Dec;17(4):439–444. doi: 10.1038/ng1297-439. [DOI] [PubMed] [Google Scholar]
- Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., De Vos R., van den Oord J. J., Collen D., Mulligan R. C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994 Mar 31;368(6470):419–424. doi: 10.1038/368419a0. [DOI] [PubMed] [Google Scholar]
- Collen D., Lijnen H. R. Fibrin-specific fibrinolysis. Ann N Y Acad Sci. 1992 Dec 4;667:259–271. doi: 10.1111/j.1749-6632.1992.tb51623.x. [DOI] [PubMed] [Google Scholar]
- DUMONDE D. C., GLYNN L. E. The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol. 1962 Aug;43:373–383. [PMC free article] [PubMed] [Google Scholar]
- Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139–266. doi: 10.1016/s0065-230x(08)60028-7. [DOI] [PubMed] [Google Scholar]
- Eitzman D. T., McCoy R. D., Zheng X., Fay W. P., Shen T., Ginsburg D., Simon R. H. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996 Jan 1;97(1):232–237. doi: 10.1172/JCI118396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gyetko M. R., Chen G. H., McDonald R. A., Goodman R., Huffnagle G. B., Wilkinson C. C., Fuller J. A., Toews G. B. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J Clin Invest. 1996 Apr 15;97(8):1818–1826. doi: 10.1172/JCI118611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamilton J. A., Campbell I. K., Wojta J., Cheung D. Plasminogen activators and their inhibitors in arthritic disease. Ann N Y Acad Sci. 1992 Dec 4;667:87–100. doi: 10.1111/j.1749-6632.1992.tb51602.x. [DOI] [PubMed] [Google Scholar]
- Kitching A. R., Holdsworth S. R., Ploplis V. A., Plow E. F., Collen D., Carmeliet P., Tipping P. G. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med. 1997 Mar 3;185(5):963–968. doi: 10.1084/jem.185.5.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kleiner D. E., Stetler-Stevenson W. G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem. 1994 May 1;218(2):325–329. doi: 10.1006/abio.1994.1186. [DOI] [PubMed] [Google Scholar]
- Koch A. E., Halloran M. M., Hosaka S., Shah M. R., Haskell C. J., Baker S. K., Panos R. J., Haines G. K., Bennett G. L., Pope R. M. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis Rheum. 1996 Sep;39(9):1566–1575. doi: 10.1002/art.1780390917. [DOI] [PubMed] [Google Scholar]
- Kruijsen M. W., van den Berg W. B., van de Putte L. B., van den Broek W. J. Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake. Agents Actions. 1981 Dec;11(6-7):640–642. doi: 10.1007/BF01978775. [DOI] [PubMed] [Google Scholar]
- König A., Mühlbauer R. C., Fleisch H. Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice. J Bone Miner Res. 1988 Dec;3(6):621–627. doi: 10.1002/jbmr.5650030607. [DOI] [PubMed] [Google Scholar]
- Martel-Pelletier J., McCollum R., Fujimoto N., Obata K., Cloutier J. M., Pelletier J. P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest. 1994 Jun;70(6):807–815. [PubMed] [Google Scholar]
- Meacock S. C., Brandon D. R., Brown C. P., Swann B. P. A novel technique for immunohistoperoxidase staining of unfixed whole joints of small animals. Histochem J. 1992 Feb;24(2):115–119. doi: 10.1007/BF01082448. [DOI] [PubMed] [Google Scholar]
- Murphy G., Atkinson S., Ward R., Gavrilovic J., Reynolds J. J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci. 1992 Dec 4;667:1–12. doi: 10.1111/j.1749-6632.1992.tb51590.x. [DOI] [PubMed] [Google Scholar]
- Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992 Dec;11(13):4825–4833. doi: 10.1002/j.1460-2075.1992.tb05588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ossowski L., Clunie G., Masucci M. T., Blasi F. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol. 1991 Nov;115(4):1107–1112. doi: 10.1083/jcb.115.4.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perez R. L., Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol. 1995 Feb 15;154(4):1879–1887. [PubMed] [Google Scholar]
- Rabbani S. A., Mazar A. P., Bernier S. M., Haq M., Bolivar I., Henkin J., Goltzman D. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem. 1992 Jul 15;267(20):14151–14156. [PubMed] [Google Scholar]
- Romer J., Bugge T. H., Pyke C., Lund L. R., Flick M. J., Degen J. L., Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med. 1996 Mar;2(3):287–292. doi: 10.1038/nm0396-287. [DOI] [PubMed] [Google Scholar]
- Ronday H. K., Smits H. H., Quax P. H., van der Pluijm G., Löwik C. W., Breedveld F. C., Verheijen J. H. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. Br J Rheumatol. 1997 Jan;36(1):9–15. doi: 10.1093/rheumatology/36.1.9. [DOI] [PubMed] [Google Scholar]
- Ronday H. K., Smits H. H., Van Muijen G. N., Pruszczynski M. S., Dolhain R. J., Van Langelaan E. J., Breedveld F. C., Verheijen J. H. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol. 1996 May;35(5):416–423. doi: 10.1093/rheumatology/35.5.416. [DOI] [PubMed] [Google Scholar]
- Sappino A. P., Huarte J., Vassalli J. D., Belin D. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest. 1991 Mar;87(3):962–970. doi: 10.1172/JCI115104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saxne T., Lecander I., Geborek P. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol. 1993 Jan;20(1):91–96. [PubMed] [Google Scholar]
- Suh T. T., Holmbäck K., Jensen N. J., Daugherty C. C., Small K., Simon D. I., Potter S., Degen J. L. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 1995 Aug 15;9(16):2020–2033. doi: 10.1101/gad.9.16.2020. [DOI] [PubMed] [Google Scholar]
- Takeda Y. Studies of the metabolism and distribution of fibrinogen in patients with rheumatoid arthritis. J Lab Clin Med. 1967 Apr;69(4):624–633. [PubMed] [Google Scholar]
- Taketazu F., Kato M., Gobl A., Ichijo H., ten Dijke P., Itoh J., Kyogoku M., Rönnelid J., Miyazono K., Heldin C. H. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest. 1994 May;70(5):620–630. [PubMed] [Google Scholar]
- Tsirka S. E., Bugge T. H., Degen J. L., Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9779–9781. doi: 10.1073/pnas.94.18.9779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vassalli J. D., Baccino D., Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol. 1985 Jan;100(1):86–92. doi: 10.1083/jcb.100.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vassalli J. D., Belin D. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett. 1987 Apr 6;214(1):187–191. doi: 10.1016/0014-5793(87)80039-x. [DOI] [PubMed] [Google Scholar]
- Vassalli J. D., Sappino A. P., Belin D. The plasminogen activator/plasmin system. J Clin Invest. 1991 Oct;88(4):1067–1072. doi: 10.1172/JCI115405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waltz D. A., Chapman H. A. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem. 1994 May 20;269(20):14746–14750. [PubMed] [Google Scholar]
- Weinberg J. B., Pippen A. M., Greenberg C. S. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1991 Aug;34(8):996–1005. doi: 10.1002/art.1780340809. [DOI] [PubMed] [Google Scholar]
- Werb Z., Mainardi C. L., Vater C. A., Harris E. D., Jr Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med. 1977 May 5;296(18):1017–1023. doi: 10.1056/NEJM197705052961801. [DOI] [PubMed] [Google Scholar]
- Xiao Q., Danton M. J., Witte D. P., Kowala M. C., Valentine M. T., Bugge T. H., Degen J. L. Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10335–10340. doi: 10.1073/pnas.94.19.10335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamamoto K., Loskutoff D. J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest. 1996 Jun 1;97(11):2440–2451. doi: 10.1172/JCI118691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zacharski L. R., Brown F. E., Memoli V. A., Kisiel W., Kudryk B. J., Rousseau S. M., Hunt J. A., Dunwiddie C., Nutt E. M. Pathways of coagulation activation in situ in rheumatoid synovial tissue. Clin Immunol Immunopathol. 1992 May;63(2):155–162. doi: 10.1016/0090-1229(92)90008-c. [DOI] [PubMed] [Google Scholar]
- van den Berg W. B., van de Loo F. A., van Lent P. L., Joosten L. A. Mechanisms of cartilage destruction in joint inflammation. Agents Actions Suppl. 1993;39:49–60. doi: 10.1007/978-3-0348-7442-7_4. [DOI] [PubMed] [Google Scholar]